PSIVIDA LIMITED | ||
|
|
|
By: | /s/ Michael J. Soja | |
Michael J. Soja |
||
Vice President, Finance and Chief Financial Officer |
EXHIBIT
99.1:
|
ASX
Release: Appendix 3Z: Final Director’s Interest Notice (Roger
Aston)
|
Name of entity | pSivida Limited |
ABN | 78 009 232 026 |
Name
of director
|
Dr
Roger Aston
|
Date
of last notice
|
3
January 2007
|
Date
that director ceased to be director
|
1
May 2007
|
Number
& class of securities
5,718,586 Ordinary
Fully Paid Shares
500,000 Unlisted
options for ordinary shares @ 61 cents expiring 31 December
2007
549,111
Unlisted options for ordinary shares @ 118 cent expiring 5 August,
2009
|
Name of holder & nature of interest |
Number
&
class
of securities
|
||||||
Note: Provide details of the circumstances giving rise to the relevant interest | |||||||
Equity (Trust) Jersey Ltd (Beneficial Owner) | 1,475,000 |
Ordinary
Full Paid Shares escrowed for a period of 6 months from
the completion of the CDS acquisition.
|
|||||
Newtonmore
Biosciences Pty Ltd
|
500,000 |
Unlisted
options for ordinary shares @ 118 cent expiring 5 August,
2009
|
+ See chapter 19 for defined terms. | |
30/9/2001 |
Appendix
3Z Page
1
|
Detail
of contract
|
|
Nature
of interest
|
|
Name
of registered holder (if
issued securities)
|
|
No.
and class of securities to which interest relates
|
+ See chapter 19 for defined terms. | |
Appendix 3Z Page 2 |
30/9/2001
|